Fate Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: La Jolla CA United States (2007)

Organization Overview

First Clinical Trial
2011
NCT00890500
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Fate Therapeutics | Fate Therapeutics, Inc